Canopy Growth Co. (NASDAQ:CGC – Get Free Report) Director Theresa Yanofsky sold 1,983 shares of the stock in a transaction that occurred on Friday, June 28th. The shares were sold at an average price of $6.41, for a total value of $12,711.03. Following the transaction, the director now directly owns 26,186 shares of the company’s stock, valued at $167,852.26. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Canopy Growth Stock Down 2.0 %
NASDAQ:CGC opened at $6.26 on Wednesday. Canopy Growth Co. has a 1 year low of $2.76 and a 1 year high of $19.20. The business has a 50 day simple moving average of $8.54 and a 200-day simple moving average of $6.36. The company has a quick ratio of 1.25, a current ratio of 1.58 and a debt-to-equity ratio of 0.99.
Canopy Growth (NASDAQ:CGC – Get Free Report) last issued its quarterly earnings results on Thursday, May 30th. The company reported ($0.28) earnings per share for the quarter, topping the consensus estimate of ($0.33) by $0.05. Canopy Growth had a negative return on equity of 62.67% and a negative net margin of 185.77%. The firm had revenue of $53.99 million for the quarter, compared to the consensus estimate of $52.71 million. As a group, research analysts anticipate that Canopy Growth Co. will post -1.08 EPS for the current year.
Institutional Trading of Canopy Growth
Wall Street Analysts Forecast Growth
Separately, Atb Cap Markets raised Canopy Growth to a “hold” rating in a research note on Monday, June 17th.
View Our Latest Stock Report on CGC
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products.
Further Reading
- Five stocks we like better than Canopy Growth
- Conference Calls and Individual Investors
- RXO Shares Surge Following New Acquisition Deal
- Investing in large cap stocks: Diving into big caps
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.